Phase-2 Trial of an Intensified Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant for Poor-Risk Leukemia

Patients with poor-risk leukemia have a high relapse rate despite allogeneic transplant. We report on the phase II trial of an intensified allogeneic transplant regimen whose aim was tolerable toxicity and durable remission. Study patients (n=30) had unfavorable first remission cytogenetics, progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Anthony S., O’Donnell, Margaret R., Synold, Timothy W., Dagis, Andrew C., Tsirunyan, Anjela, Nademanee, Auayporn P., Parker, Pablo M., Pullarkat, Vinod A., Snyder, David S., Spielberger, Ricardo T., Wong, Jeffrey Y.C., Alvarnas, Joseph C., Thomas, Sandra H., Forman, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203202/
https://www.ncbi.nlm.nih.gov/pubmed/21151180
http://dx.doi.org/10.1038/bmt.2010.295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203202/
https://www.ncbi.nlm.nih.gov/pubmed/21151180
http://dx.doi.org/10.1038/bmt.2010.295

Ejemplares similares